CUTISS AG
PrivateLast Round
Series C
Sep 10, 2025
Total Funding Raised
$101.96M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CUTISS AG is a Swiss life sciences company that develops personalized, bio-engineered skin grafts to treat large and deep skin defects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CUTISS AG Comparables
Compare CUTISS AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioLab Sciences | 80% | |
| PolarityBio, Inc. | 77% | |
| Keenova Therapeutics plc | 77% | |
CUTISS AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 10, 2025 | ||||
| Grant | May 2, 2023 | ||||
| Series B | Jun 29, 2020 | ||||
| Grant | Aug 19, 2019 | ||||
| Grant | Sep 1, 2018 | ||||
Series A | Jun 20, 2018 |
Key People
Founding team and executive leadership
CUTISS AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon 2020 | Grant |
| European Commission | Grant |
| Yellowstone Holding AG | Series A |
| Swisspreneur Syndicate | Series C |
| Wyss Foundation | Series B |
| Innosuisse | Grant |
| University of Zurich | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 20, 2026
Launched a process for manufacturing personalized, living skin.
- Oct 1, 2025
denovoSkin™ successfully completed Phase I clinical trials in burns patients.
CUTISS AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CUTISS AG's valuation, stock price, and market status.